Literature DB >> 10549806

Primary cultures of neuronal and non-neuronal rat brain cells secrete similar proportions of amyloid beta peptides ending at A beta40 and A beta42.

H Fukumoto1, T Tomita, H Matsunaga, Y Ishibashi, T C Saido, T Iwatsubo.   

Abstract

To determine the types of brain cells responsible for the production of amyloid beta peptides (A beta), as well as their carboxyl-terminal properties, we studied the secretion of A beta in rat neuronal, astrocytic, microglial and meningeal primary cell cultures. All four types of cells produced A beta, among which neurons secreted approximately 4 times more A beta than other cell types. The percentage of A beta42 ending at position 42 as a fraction of total A beta was similar between different cell types, ranging from 10 to 15%. These results suggest that neurons might be the most potent source for A beta production in the brain, although other non-neuronal type cells could also contribute to this process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549806     DOI: 10.1097/00001756-199909290-00017

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease.

Authors:  Hiroaki Fukumoto; Hideki Takahashi; Naoki Tarui; Junji Matsui; Taisuke Tomita; Mitsuhiro Hirode; Masumi Sagayama; Ryouta Maeda; Makiko Kawamoto; Kazuko Hirai; Jun Terauchi; Yasufumi Sakura; Mitsuru Kakihana; Kaneyoshi Kato; Takeshi Iwatsubo; Masaomi Miyamoto
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

2.  C terminus of presenilin is required for overproduction of amyloidogenic Abeta42 through stabilization and endoproteolysis of presenilin.

Authors:  T Tomita; R Takikawa; A Koyama; Y Morohashi; N Takasugi; T C Saido; K Maruyama; T Iwatsubo
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  Amyloid-β-induced amyloid-β secretion: a possible feed-forward mechanism in Alzheimer's Disease.

Authors:  Ian T Marsden; Laurie S Minamide; James R Bamburg
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV.

Authors:  Tadafumi Hashimoto; Tomoko Wakabayashi; Atsushi Watanabe; Hisatomo Kowa; Ritsuko Hosoda; Atsushi Nakamura; Ichiro Kanazawa; Takao Arai; Koji Takio; David M A Mann; Takeshi Iwatsubo
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

5.  BACE1 activity is modulated by cell-associated sphingosine-1-phosphate.

Authors:  Nobumasa Takasugi; Tomoki Sasaki; Kunimichi Suzuki; Satoko Osawa; Hayato Isshiki; Yukiko Hori; Naoaki Shimada; Takuya Higo; Satoshi Yokoshima; Tohru Fukuyama; Virginia M-Y Lee; John Q Trojanowski; Taisuke Tomita; Takeshi Iwatsubo
Journal:  J Neurosci       Date:  2011-05-04       Impact factor: 6.167

6.  Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease.

Authors:  Catia Bellucci; Cinzia Lilli; Tiziano Baroni; Lucilla Parnetti; Sandro Sorbi; Carla Emiliani; Eleonora Lumare; Paolo Calabresi; Stefania Balloni; Maria Bodo
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

7.  Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.

Authors:  Hisatomo Kowa; Tomoko Sakakura; Yusuke Matsuura; Tomoko Wakabayashi; David M A Mann; Karen Duff; Shoji Tsuji; Tadafumi Hashimoto; Takeshi Iwatsubo
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

8.  GPR120 signaling controls amyloid-β degrading activity of matrix metalloproteinases.

Authors:  Kazunori Kikuchi; Takuya Tatebe; Yuki Sudo; Miyabishara Yokoyama; Kiwami Kidana; Yung Wen Chiu; Sho Takatori; Makoto Arita; Yukiko Hori; Taisuke Tomita
Journal:  J Neurosci       Date:  2021-06-04       Impact factor: 6.167

9.  FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons.

Authors:  Nobumasa Takasugi; Tomoki Sasaki; Ihori Ebinuma; Satoko Osawa; Hayato Isshiki; Koji Takeo; Taisuke Tomita; Takeshi Iwatsubo
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

10.  Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (A β ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy.

Authors:  Anchalee Prasansuklab; Tewin Tencomnao
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.